A detailed history of Verition Fund Management LLC transactions in Enovis Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 9,677 shares of ENOV stock, worth $448,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,677
Previous 139,454 93.06%
Holding current value
$448,335
Previous $6.3 Million 93.4%
% of portfolio
0.0%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.57 - $48.1 $5.27 Million - $6.24 Million
-129,777 Reduced 93.06%
9,677 $416,000
Q2 2024

Aug 14, 2024

BUY
$44.56 - $62.43 $6.21 Million - $8.71 Million
139,454 New
139,454 $6.3 Million
Q3 2022

Nov 14, 2022

BUY
$46.07 - $60.1 $558,967 - $729,193
12,133 New
12,133 $559,000
Q2 2022

Aug 15, 2022

SELL
$55.0 - $70.47 $293,370 - $375,886
-5,334 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$62.07 - $80.84 $331,081 - $431,200
5,334 New
5,334 $212,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.51B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.